# China NMPA Product Recall - Disposable biopsy needle (trade name: Max-Core)

Source: https://www.globalkeysolutions.net/records/china_product_recall/bard-peripheral-vascular-inc/748efe26-ecad-4e26-b5df-7fb199c22ed5/
Source feed: China

> China NMPA product recall for Disposable biopsy needle (trade name: Max-Core) by Bard Peripheral Vascular, Inc. published May 29, 2015. Recall level: . On May 29, 2015, the National Medical Products Administration (NMPA) announced a significant product

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Bard Peripheral Vascular, Inc. is recalling its single-use biopsy needle (brand name: Max-Core).
- Company Name: Bard Peripheral Vascular, Inc.
- Publication Date: 2015-05-29
- Product Name: Disposable biopsy needle (trade name: Max-Core)
- Recall Reason: Exhibits self-excitation defects
- Discovering Company: Bard Medical Technology (Shanghai) Co., Ltd.
- Manufacturing Company: Bard Peripheral Vascular, Inc.
- Summary: On May 29, 2015, the National Medical Products Administration (NMPA) announced a significant product recall initiated by Bard Peripheral Vascular, Inc. concerning their single-use biopsy needles, marketed under the trade name Max-Core. The recall stemmed from a critical safety defect: the needles exhibited a self-ignition issue, which regrettably resulted in injuries to customers. Bard Medical Technology (Shanghai) Co., Ltd., played a role in reporting this serious flaw, leading to the voluntary recall by the manufacturer.

The recalled product, registered under the CFDA (Imported) No. 20143150789, was explicitly stated by Bard Peripheral Vascular, Inc. not to have been sold within the Chinese market. Despite this, the NMPA proactively addressed the situation within its regulatory framework. It issued a directive requesting that all provincial, autonomous region, and municipal food and drug administrations reinforce their supervision and management protocols. This action demonstrates the NMPA's commitment to monitoring medical product safety, even when issues originate with products not directly distributed domestically. The recall highlights the manufacturer's immediate responsibility to acknowledge and rectify safety hazards, ensuring consumer protection globally, and the regulatory body's overarching mandate to maintain public health standards.

Company: https://www.globalkeysolutions.net/companies/bard-peripheral-vascular-inc/12056f40-c9c7-45e9-b305-900ec162d183/